Iovance Biotherapeutics Inc (IOVA)
13.63
+0.75
(+5.82%)
USD |
NASDAQ |
May 03, 16:00
13.58
-0.05
(-0.37%)
After-Hours: 20:00
Iovance Biotherapeutics Debt to Equity Ratio: 0.0017 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0017 |
| September 30, 2023 | 0.0015 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0017 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0015
Minimum
Sep 2023
0.0017
Maximum
Jun 2023
0.0016
Average
0.0017
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| QuidelOrtho Corp | 0.4824 |
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 780.35M |
| Total Liabilities (Quarterly) | 195.74M |
| Shareholders Equity (Quarterly) | 584.61M |
| Current Ratio | 2.791 |